Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression

Ariela Noy; Lawrence Kaplan; Jeannette Lee; Ethel Cesarman; Wayne Tam

首页> 外文期刊>Infectious Agents and Cancer >Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression

【24h】

Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression

机译：改良的剂量密集型R-CODOX-M / IVAC用于与HIV相关的伯基特（BL）（AMC 048）具有疗效和耐受性，并具有IRF4 / MUM1表达的预测潜力

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Infectious Agents and Cancer》 |2012年第s1期|共页
作者
Ariela Noy; Lawrence Kaplan; Jeannette Lee; Ethel Cesarman; Wayne Tam;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献

1. AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma [J] . Noy Ariela, Lee Jeannette Y., Cesarman Ethel, Blood: The Journal of the American Society of Hematology . 2015,第2期

机译：AMC 048：改良的CODOX-M / IVAC-利妥昔单抗对与HIV相关的伯基特淋巴瘤安全有效
2. HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era [J] . J. A. Rodrigo, L. K. Hicks, M. C. Cheung, Advances in hematology . 2012,第Pta1期

机译：艾滋病毒相关的伯基特淋巴瘤：良好的疗效和耐受性强，包括在HAART时代使用或不使用利妥昔单抗的CODOX-M / IVAC
3. HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era [J] . J. A.Rodrigo, L. K.Hicks, M. C.Cheung, Advances in hematology . 2012,第1期

机译：艾滋病毒相关的伯基特淋巴瘤：良好的疗效和耐受性强，包括在HAART时代使用或不使用利妥昔单抗的CODOX-M / IVAC
4. Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability and predictive potential of IRF4/MUM1 expression [O] . Ariela Noy, Lawrence Kaplan, Jeannette Lee, 2012

机译：改良的剂量密集型R-CODOX-M / IVAC用于与HIV相关的伯基特（BL）（AMC 048）具有疗效和耐受性并具有IRF4 / MUM1表达的预测潜力
5. Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression [O] . Noy Ariela, Kaplan Lawrence, Lee Jeannette, 2012

机译：改良的剂量密集型R-CODOX-M / IVAC用于与HIV相关的伯基特（BL）（AMC 048）具有疗效和耐受性，并具有IRF4 / MUM1表达的预测潜力

Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression

著录项

相似文献

相关主题

期刊订阅